ReviewInternational journal of molecular sciences2026

GNMT and Its Regulatory MicroRNAs as Biomarkers and Therapeutic Targets for Metabolic Dysfunction-Associated Fatty Liver Disease and Hepatocellular Carcinoma.

Yung-Chi Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.